Monza, Italy

Viviana Frigeni


Average Co-Inventor Count = 3.9

ph-index = 2

Forward Citations = 4(Granted Patents)


Location History:

  • Monza Mi, IT (1986)
  • Monza, IT (1985 - 1990)

Company Filing History:


Years Active: 1985-1990

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Viviana Frigeni: Innovator in Pharmaceutical Compounds

Introduction

Viviana Frigeni is a notable inventor based in Monza, Italy. She has made significant contributions to the pharmaceutical field, particularly through her innovative compounds that exhibit anti-allergic, anti-anaphylactic, and anti-arthritic activities. With a total of 4 patents to her name, her work continues to impact the industry positively.

Latest Patents

Frigeni's latest patents include the development of 4-(3-Coumarinyl)-thiazole-derivatives, which are described as having anti-allergic properties. These compounds, along with their preparation methods, are detailed in her patents. Additionally, she has worked on benzopyran[4,3-d]-thiazole-derivatives, which also demonstrate similar beneficial activities in the pharmaceutical field. The compositions for pharmaceutical use containing these compounds as active ingredients are also outlined in her patents.

Career Highlights

Throughout her career, Viviana Frigeni has been associated with prominent companies such as Zambon S.p.A. and Zambon Group S.p.A. Her work in these organizations has allowed her to develop and refine her innovative ideas, contributing to her success as an inventor.

Collaborations

Frigeni has collaborated with notable colleagues, including Angelo Carenzi and Dario Chiarino. These partnerships have likely enhanced her research and development efforts, leading to her successful patent applications.

Conclusion

Viviana Frigeni stands out as a significant figure in the realm of pharmaceutical innovations. Her contributions through her patents reflect her dedication to advancing medical science and improving health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…